Jpmorgan Chase & Co »

Oncolytics Biotech shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $157 163 0.96

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Oncolytics Biotech

Marshall Wace
XTX Topco
Seeds Investor
International Assets Investment Management
Connective Capital Management
Goldman Sachs Group
Tocqueville Asset Management
Everhart Financial Group
Susquehanna International
PFG Investments
Hrt Financial
Invesco
Doliver Capital Advisors
LPL Financial
Franklin Resources

View all funds holding Oncolytics Biotech